Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal

Rajabrata Sarkar, R. Clinton Webb

Research output: Contribution to journalReview article

69 Citations (Scopus)

Abstract

Smooth muscle proliferation is involved in the pathogenesis of atherosclerosis, restenosis after angioplasty and vein graft failure due to neointimal hyperplasia. Nitric oxide (NO) inhibits smooth muscle cell growth in vitro and experimental neointimal hyperplasia in vivo, suggesting a role for NO as a regulator of smooth muscle cell proliferation. NO is also involved in the control of numerous other vascular functions including platelet and inflammatory cell adhesion, vascular reactivity and endothelial permeability. This review critically examines the experimental and clinical evidence that supports a role for NO as a modulator of smooth muscle cell proliferation, with an emphasis on the multiple mechanisms by which NO acts on vascular lesions.

Original languageEnglish (US)
Pages (from-to)135-142
Number of pages8
JournalJournal of Vascular Research
Volume35
Issue number3
DOIs
StatePublished - May 1 1998

Fingerprint

Smooth Muscle Myocytes
Nitric Oxide
Cell Proliferation
Blood Vessels
Hyperplasia
Angioplasty
Cell Adhesion
Smooth Muscle
Veins
Permeability
Atherosclerosis
Blood Platelets
Transplants
Growth

Keywords

  • Arginine
  • Atherosclerosis
  • Balloon angioplasty
  • Endothelium
  • Restenosis
  • Vasodilators

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal. / Sarkar, Rajabrata; Webb, R. Clinton.

In: Journal of Vascular Research, Vol. 35, No. 3, 01.05.1998, p. 135-142.

Research output: Contribution to journalReview article

@article{eae6b989b07542a7abd757e6d82a45d3,
title = "Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal",
abstract = "Smooth muscle proliferation is involved in the pathogenesis of atherosclerosis, restenosis after angioplasty and vein graft failure due to neointimal hyperplasia. Nitric oxide (NO) inhibits smooth muscle cell growth in vitro and experimental neointimal hyperplasia in vivo, suggesting a role for NO as a regulator of smooth muscle cell proliferation. NO is also involved in the control of numerous other vascular functions including platelet and inflammatory cell adhesion, vascular reactivity and endothelial permeability. This review critically examines the experimental and clinical evidence that supports a role for NO as a modulator of smooth muscle cell proliferation, with an emphasis on the multiple mechanisms by which NO acts on vascular lesions.",
keywords = "Arginine, Atherosclerosis, Balloon angioplasty, Endothelium, Restenosis, Vasodilators",
author = "Rajabrata Sarkar and Webb, {R. Clinton}",
year = "1998",
month = "5",
day = "1",
doi = "10.1159/000025576",
language = "English (US)",
volume = "35",
pages = "135--142",
journal = "Journal of Vascular Research",
issn = "1018-1172",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal

AU - Sarkar, Rajabrata

AU - Webb, R. Clinton

PY - 1998/5/1

Y1 - 1998/5/1

N2 - Smooth muscle proliferation is involved in the pathogenesis of atherosclerosis, restenosis after angioplasty and vein graft failure due to neointimal hyperplasia. Nitric oxide (NO) inhibits smooth muscle cell growth in vitro and experimental neointimal hyperplasia in vivo, suggesting a role for NO as a regulator of smooth muscle cell proliferation. NO is also involved in the control of numerous other vascular functions including platelet and inflammatory cell adhesion, vascular reactivity and endothelial permeability. This review critically examines the experimental and clinical evidence that supports a role for NO as a modulator of smooth muscle cell proliferation, with an emphasis on the multiple mechanisms by which NO acts on vascular lesions.

AB - Smooth muscle proliferation is involved in the pathogenesis of atherosclerosis, restenosis after angioplasty and vein graft failure due to neointimal hyperplasia. Nitric oxide (NO) inhibits smooth muscle cell growth in vitro and experimental neointimal hyperplasia in vivo, suggesting a role for NO as a regulator of smooth muscle cell proliferation. NO is also involved in the control of numerous other vascular functions including platelet and inflammatory cell adhesion, vascular reactivity and endothelial permeability. This review critically examines the experimental and clinical evidence that supports a role for NO as a modulator of smooth muscle cell proliferation, with an emphasis on the multiple mechanisms by which NO acts on vascular lesions.

KW - Arginine

KW - Atherosclerosis

KW - Balloon angioplasty

KW - Endothelium

KW - Restenosis

KW - Vasodilators

UR - http://www.scopus.com/inward/record.url?scp=0031812583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031812583&partnerID=8YFLogxK

U2 - 10.1159/000025576

DO - 10.1159/000025576

M3 - Review article

C2 - 9647326

AN - SCOPUS:0031812583

VL - 35

SP - 135

EP - 142

JO - Journal of Vascular Research

JF - Journal of Vascular Research

SN - 1018-1172

IS - 3

ER -